165 related articles for article (PubMed ID: 35734176)
1. Membranous Nephropathy Secondary to Graves' Disease: A Case Report.
Neves PDMM; Muniz MPR; Morgantetti GF; Cutrim ÉMM; Macieira CA; Salgado-Filho N; Lages JS; Brito DJA; Cunha KA; Gatto GC; Silva GEB
Front Immunol; 2022; 13():824124. PubMed ID: 35734176
[TBL] [Abstract][Full Text] [Related]
2. A case of membranous nephropathy secondary to asymptomatic Graves' disease.
Moniwa N; Shioya Y; Gocho Y; Takahashi S; Tanaka M; Furuhashi M; Kuroda S; Hama T; Shima Y; Ogawa Y; Miura T
CEN Case Rep; 2022 Aug; 11(3):309-313. PubMed ID: 34988884
[TBL] [Abstract][Full Text] [Related]
3. Proteinuria in a patient with Graves' disease: Answers.
Dagdeviren Cakir A; Canpolat N; Saygili S; Kilicaslan I; Turan H; Ercan O; Evliyaoglu O
Pediatr Nephrol; 2019 Aug; 34(8):1383-1385. PubMed ID: 30843111
[No Abstract] [Full Text] [Related]
4. [A case of membranous nephropathy with ANCA-associated necrotizing glomerulonephritis during oral administration of PTU for Graves' disease].
Fujii T; Kawamata T; Ueda S; Akikusa B; Hasegawa S; Tsukahara T; Iesato K; Ogawa M; Saisho H
Nihon Jinzo Gakkai Shi; 2003; 45(8):771-7. PubMed ID: 14737995
[TBL] [Abstract][Full Text] [Related]
5. Primary membranous glomerulonephritis with negative serum PLA2R in haemophilia A successfully managed with rituximab - case report and review of the literature.
Meyer N; Cooper W; Kirwan P; Garsia R; Dunkley S; Gracey DM
BMC Nephrol; 2021 Jul; 22(1):268. PubMed ID: 34294065
[TBL] [Abstract][Full Text] [Related]
6. Membranous nephropathy associated with thyroid-peroxidase antigen.
Shima Y; Nakanishi K; Togawa H; Obana M; Sako M; Miyawaki M; Nozu K; Iijima K; Yoshikawa N
Pediatr Nephrol; 2009 Mar; 24(3):605-8. PubMed ID: 18762990
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
8. Relationship between autoimmune thyroid disease and nephropathy: A clinicopathological study.
Zhao L; Liu Y; Su H; Shi X
Medicine (Baltimore); 2021 Jun; 100(23):e26273. PubMed ID: 34115025
[TBL] [Abstract][Full Text] [Related]
9. First case report of PLA2R-related monotypic (IgG-κ positive) membranous nephropathy concurrent with leukocyte chemotactic factor 2 amyloidosis.
Xu J; Wang X; Weng Q; Feng X; Pan X
BMC Nephrol; 2023 Sep; 24(1):283. PubMed ID: 37752421
[TBL] [Abstract][Full Text] [Related]
10. Membranous nephropathy secondary to Graves' disease with deposits of thyroid peroxidase in an adult.
Sasaki K; Yasuda K; Nakanishi K; Rakugi H; Isaka Y; Yamato M
CEN Case Rep; 2014 May; 3(1):90-93. PubMed ID: 28509253
[TBL] [Abstract][Full Text] [Related]
11. Proteinuria in autoimmune thyroid disease.
Weetman AP; Tomlinson K; Amos N; Lazarus JH; Hall R; McGregor AM
Acta Endocrinol (Copenh); 1985 Jul; 109(3):341-7. PubMed ID: 3839619
[TBL] [Abstract][Full Text] [Related]
12. Membranous nephropathy and thrombotic microangiopathy secondary to metastatic prostate cancer after Iodine-125 prostate brachytherapy: A case report
.
Yang L; Liang D; Cheng S; Ge Y
Clin Nephrol; 2019 Sep; 92(3):155-158. PubMed ID: 31262399
[TBL] [Abstract][Full Text] [Related]
13. PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.
Hoxha E; Harendza S; Pinnschmidt H; Panzer U; Stahl RA
PLoS One; 2014; 9(10):e110681. PubMed ID: 25313791
[TBL] [Abstract][Full Text] [Related]
14. Membranous nephropathy with crescents: a series of 19 cases.
Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
[TBL] [Abstract][Full Text] [Related]
15. Hashimoto's thyroiditis following Graves' disease.
Umar H; Muallima N; Adam JM; Sanusi H
Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase A2 receptor positive membranous nephropathy long after living donor kidney transplantation between identical twins.
Saito H; Hamasaki Y; Tojo A; Shintani Y; Shimizu A; Nangaku M
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():101-4. PubMed ID: 26031599
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report.
Ishiwatari A; Wakai S; Shirakawa H; Honda K
Transplant Proc; 2018 Oct; 50(8):2565-2568. PubMed ID: 30316399
[TBL] [Abstract][Full Text] [Related]
18. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A
Tominaga K; Uchida T; Imakiire T; Itoh K; Shimazaki H; Nakanishi K; Kumagai H; Oshima N
BMC Nephrol; 2018 May; 19(1):120. PubMed ID: 29792176
[TBL] [Abstract][Full Text] [Related]
19. A cohort study of membranous nephropathy, primary or secondary.
Arghiani M; Zamani BH; Nazemian F; Samadi S; Afsharian MS; Habibzadeh M; Eslami S; Sabbagh MG
BMC Nephrol; 2021 Apr; 22(1):138. PubMed ID: 33874909
[TBL] [Abstract][Full Text] [Related]
20. Membranous glomerulonephritis associated with Graves' disease.
Becker BA; Fenves AZ; Breslau NA
Am J Kidney Dis; 1999 Feb; 33(2):369-73. PubMed ID: 10023652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
